This inventor holds 1 USPTO granted patent. Top assignee: Mirus Bio Corporation. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: The Innovative Contributions of Matthew R. Wolff
Introduction
Matthew R. Wolff is a notable inventor based in Middleton, Wisconsin. He has made significant contributions to the field of gene therapy through his innovative processes. His work focuses on delivering nucleic acids to cardiac tissue, which has important implications for medical research and treatment.
Latest Patents
Matthew R. Wolff holds a patent for a process titled "Process for delivering nucleic acids to cardiac tissue." This patent describes a method for introducing a composition consisting of a nucleic acid into a blood vessel, which subsequently delivers the nucleic acid to cardiac tissue cells in mammals. The nucleic acid can be DNA, RNA, plasmid DNA, or viral, and this process is aimed at advancing gene therapy and research.
Career Highlights
Matthew is currently associated with Mirus Bio Corporation, where he applies his expertise in biotechnology and gene therapy. His work at the company has positioned him as a key player in the development of innovative solutions for medical challenges.
Collaborations
Some of his notable coworkers include Jon Asher Wolff and Hans Herweijer, who contribute to the collaborative environment at Mirus Bio Corporation.
Conclusion
Matthew R. Wolff's contributions to the field of gene therapy through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the delivery of nucleic acids for therapeutic purposes.